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Abstract. In the last years an increasing demand for Grid Infrastructures has resulted in 
several international collaborations. This is the case of the EELA Project, which has 
brought together collaborating groups of Latin America and Europe. One year ago we 
presented this e-infrastructure used, among others, by the Biomedical groups for the studies 
of oncological analysis, neglected diseases, sequence alignments and computation 
phylogenetics. After this period, the achieved advances are summarised in this paper. 
 
1. Introduction 
 
Funded by the European Commission, the EELA Project (E-Infrastructure shared between 
Europe and Latin America) [1] began in January 2006 to build a digital bridge between the 
existing e-Infrastructure initiatives in Europe and those that were emerging in Latin 
America, throughout the creation of a collaborative network that shares an interoperable 
Grid infrastructure to support the development and test of advanced applications. 
 
One of the identified areas of work in scientific research is Biomedicine and, consequently,  
the applications that can be ported to the Grid. Some of them, falling in the three typical 
categories of Bioinformatics Applications, Computational Biochemical Processes and 
Biomedical Models, were selected [2] and started to be deployed on the pilot EELA 
infrastructures for both production and dissemination purposes. 
 
This document describes the achieved advances in these biomedicine applications in the 
last year. For a more detailed explanation of them, the reader can consult [2] and [3]. 
 
2. GATE 
 
The C++ platform based on the Monte Carlo GEANT4 software [4] GATE (GEANT4 
Application for Tomographic Emission) [5] models nuclear medicine applications, such as 
PET and SPECT within the OpenGATE collaboration [6]. The computational-intensive 
Monte Carlo simulations prevent hospitals and clinical centres from using them for daily 
practice in radiotherapy and brachytherapy treatment planning. As a result, the objective of 
GATE is to use the Grid environment to reduce the computing time of Monte Carlo 
simulations providing a higher accuracy in a reasonable period of time 
 
Nine Cuban centres are currently testing, as users, the results of the simulation of 
radiotherapy treatments using realistic models that GATE provides in two main oncological 
problems: 
 Thyroid Cancer (the diseases of thyroids are one of the 5 main causes of Endocrinology 
treatments) [7]; and, 
 Treatment of metastasis with P32 isotopes [8] by means of the brachytherapy improving 
the knowledge on the doses captured from the different tissues by accurate simulation. 
 
The EELA consortium has provided the support for the installation and integration of a 
small Grid site in Cuba in order to run the simplest jobs concerning Monte Carlo 
simulations. For those cases where the computer load is greater, a previous preparation of 
the job is done in Cuba and, after that, the necessary material is brought physically to 
another EELA sites with a higher bandwidth in order to do the submission process. 
 
Besides of that, some researchers have stayed as fellowships for a long period at the 
ITACA–GRyCAP department (Valencia, Spain) with the support of the EELA funds 
improving their knowledge in Grid and GATE technologies. 
 
As a conclusion, Grid will increase the performance to the application, but in this case, it 
will even be more important, since it is an enabling technology opening the doors to a new 
range of applications and possibilities. All the centres from Cuba currently testing this 
application bring to the EELA community around 90 cases per month. 
 
3. WISDOM 
 
The objective of WISDOM (Wide in Silico Docking of Malaria) is the proposition of new 
inhibitors for a family of proteins produced by Plasmodium Falciparum due to this 
protozoan parasite causes malaria and affects around 300 million people and more than 4 
thousand people die daily in the world. The cross-resistance to antimalarials produced by 
the focus on a limited number of biological targets has derived in a drug resistance for all 
classes of antimalarials except artemisinins. Because of this the development of new drugs 
with new targets is necessary, but the process is cost so the economic profit is not clear for 
the drug manufacturers. 
 
This WISDOM application consists on the deployment of a high throughput virtual 
screening platform in the perspective of in silico drug discovery for neglected diseases. 
 
The interest of the EELA partners centred in three actions: 
 The study of new targets for new parasitory diseases. 
 The selection of new targets for malaria. 
 The contribution with resources for the WISDOM Data Challenge. 
 
The WISDOM platform [9] has performed in the Fall of 2006 its second High-Throughput 
virtual Docking of million of chemical compounds available in the databases of ligands to 
several targets. In this WISDOM Data Challenge-II [10] ULA has proposed two targets in 
Plasmodium Vivax which have been accepted by the consortium and docked within the 
EELA as was agreed by the WISDOM DC-II decision-makers. This process has been 
coordinated by UPV and all the EELA sites have acted as donor of computational and 
storage resources. The results will be presented in future works. 
 
4. BLAST in Grid 
 
The study of the functionality of the different genes and regions is one of the most 
important efforts on the analysis of the genome. If the queries and the alignments are well 
designed both functional and evolutionary information can be inferred from sequence 
alignments since they provide a powerful way to compare novel sequences with previously 
characterised genes. 
 
The Basic Local Alignment Search Tool (BLAST) [11] finds regions of local similarity 
between sequences. The program compares nucleotide or protein sequences to databases 
and calculates the statistical significance of matches. This process of finding homologous 
of sequences is very computationally-intensive since the searching alignment of a single 
sequence is not a costly task, but normally, thousands of sequences are searched at the same 
time. 
 
The biocomputing community usually relies on either local installations or public servers, 
such as the NCBI [12] or the gPS@ [13], but the limitations on the number of simultaneous 
queries make this environment inefficient for large tests. Moreover, since the databases are 
periodically updated, it will be convenient to do the same with the results of previous 
studies. 
 
BLAST has been ported to the Grid according to different approaches [14] because the 
number of fragments to be analysed and the periodical updating of the information will be 
increased. EELA has adopted the availability of an independent Grid-enabled version 
integrated on the Bioinformatics Portal of the Universidad de los Andes [15] providing 
registered users with results in a shorter time. Basically the users access the service through 
this web portal and, after that, to the EELA Grid with a Gate-to-Grid, i. e., an EELA Grid 
node which provides a WSRF-Based web interface. The security is provided by means of a 
MyProxy server which generates manually and temporally certificates that will be retrieved 
by the UI when required. 
 
BLAST in Grid (BiG) has been used for searching similar sequences and inferring their 
function in parasite diseases such as the Leishmaniasis (mainly Mexican Leishmania), 
Chagas (mainly Trypanosoma Cruzi) and Malaria (mainly Plasmodium vivax). 
 
5. Phylogeny (MrBayes) 
 
A phylogeny is a reconstruction of the evolutionary history of a group of organisms used 
throughout the life sciences, as it offers a structure around which to organize the knowledge 
and data accumulated by researchers. Computational phylogenetics has been a rich area for 
algorithm design over the last 15 years. The inference of phylogenies with computational 
methods is widely used in medical and biological research and has many important 
applications, such as gene function prediction, drug discovery and conservation biology 
[16]. 
 
The most commonly used methods to infer phylogenies include cladistics, phenetics, 
maximum likelihood, and Markov Chain Monte Carlo (MCMC) based Bayesian inference. 
These last two depend upon a mathematical model describing the evolution of characters 
observed in the included species, and are usually used for molecular phylogeny where the 
characters are aligned nucleotide or amino acid sequences. 
 
Due to the nature of Bayesian inference, the simulation can be prone to entrapment in local 
optima. To overcome local optima and achieve better estimation, the MrBayes program 
[17] has to run for millions of iterations (generations) which require a large amount of 
computation time. For multiple sessions with different models or parameters, it will take a 
very long time before the results can be analyzed and summarized. 
 
The phylogenetic tools are widely demanded by the Latin America bioinformatics 
community.  A Grid service for the parallelised version of MrBayes application is currently 
being developed and a simple interface will be deployed on the bioinformatics portal of 
Universidad de los Andes [18] in a similar way to that done for BiG. Nevertheless, some 
previous works with this parallelization have been successfully submitted and executed in 
the EELA infrastructure and been demonstrated in the first EELA conference [19]. 
 
6. Conclusion and new challenges 
 
The EELA e-infrastructure is permitting various collaborative groups in Latin America to 
use more powerful computational resources than those available on their centers. This 
achieves that the lines of investigation stated in the document can be feasible as the 
computational requirements for them are being met and new results are being offered to the 
scientific community. 
 
The EELA project currently has four biomedical pilot applications running, but is also 
looking for new ones. For this purpose, it is offering its support with initiatives like Grid 
School [20]. As a result, new biomedical applications such as EMBOSS [21] will be ported 
to the Grid very soon. With this free Open Source software analysis package specially 
developed for the needs of the molecular biology user community EELA will keep on 
working in the Biomedical field. 
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